Literature DB >> 11694517

Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis.

Anthony D Cristillo1, Barbara E Bierer.   

Abstract

The immunosuppressive agents cyclosporin A (CsA) and tacrolimus (FK506) bind to unrelated intracellular immunophilin receptors, cyclophilin (CyP) and FK506-binding protein (FKBP), respectively. The complexes of CsA-CyP and of FK506-FKBP both bind to and inhibit the activity of the calcium/calmodulin-dependent serine/threonine phosphatase calcineurin. We used cDNA microarray analysis to characterize early human peripheral blood T cell transcriptional responses following antigen receptor stimulation in the absence or presence of CsA or FK506, hoping to identify novel targets dependent upon calcineurin or immunophilins or, perhaps, specific targets of either CyP or FKBP inhibitable by one drug alone. The array data failed to identify genes uniquely sensitive to only one drug, suggesting that transcriptionally regulated, immunophilin-dependent but calcineurin-independent targets fell below the limits of detection in this system. In contrast, transcript profiling identified and mRNA and protein analysis confirmed novel as well as known genes reproducibly induced or inhibited by both immunosuppressive agents. In this context, we show that transcriptional activation of Stat5a and repression of the cytokine interleukin-16 are regulated by T cell receptor engagement and dependent upon drug-immunophilin complexes and, presumably, calcineurin activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694517     DOI: 10.1074/jbc.M108598200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Calcineurin-independent inhibition of mitochondrial Ca2+ uptake by cyclosporin A.

Authors:  M Montero; C D Lobatón; S Gutierrez-Fernández; A Moreno; J Alvarez
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

2.  Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability.

Authors:  Chris Cheadle; Jinshui Fan; Yoon S Cho-Chung; Thomas Werner; Jill Ray; Lana Do; Myriam Gorospe; Kevin G Becker
Journal:  BMC Genomics       Date:  2005-05-20       Impact factor: 3.969

3.  Counter-regulation of T cell effector function by differentially activated p38.

Authors:  Muhammad S Alam; Matthias M Gaida; Youichi Ogawa; Antonios G A Kolios; Felix Lasitschka; Jonathan D Ashwell
Journal:  J Exp Med       Date:  2014-05-26       Impact factor: 14.307

4.  Distinct Transcriptional Profile of PDZ Genes after Activation of Human Macrophages and Dendritic Cells.

Authors:  Jorge Rosas-García; Lucero A Ramón-Luing; Karen Bobadilla; Marco Antonio Meraz-Ríos; Edgar E Sevilla-Reyes; Teresa Santos-Mendoza
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

5.  Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.

Authors:  Vilija Oke; Iva Gunnarsson; Aliisa Häyry; Francesca Faustini; Agneta Zickert; Anders Larsson; Timothy B Niewold; Elisabet Svenungsson
Journal:  Lupus Sci Med       Date:  2022-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.